RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

CUSIP: 75629V104

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Class A Common Stock
Shares outstanding
514,715,255
Total 13F shares
264,392,743
Share change
+9,331,280
Total reported value
$1,743,289,324
Put/Call ratio
172%
Price per share
$6.59
Number of holders
262
Value change
+$54,064,157
Number of buys
150
Number of sells
95

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q3 2024

As of 30 Sep 2024, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 262 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 264,392,743 shares. The largest 10 holders included ARK Investment Management LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Mubadala Investment Co PJSC, STATE STREET CORP, Kinnevik AB (publ), Sumitomo Mitsui Trust Group, Inc., and Nikko Asset Management Americas, Inc.. This page lists 263 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.